Popular on eTradeWire


Similar on eTradeWire

Anti-TCR alpha/beta Antibody Conjugated to PE

eTradeWire News/10771996
SAN DIEGO - eTradeWire -- Anti-TCR alpha/beta Antibody Conjugated to PE

Anti-TCR alpha/beta Antibody Conjugated to PE is a high quality antibody that specifically targets the T cell receptor (TCR) alpha/beta complex and is conjugated to a fluorescent dye called phycoerythrin (PE). This conjugated antibody can be used in flow cytometry to detect and analyze T cells expressing the TCR alpha/beta complex. The PE fluorescence allows for the visualization and quantification of these specific T cells in a sample. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.

Anti-TCR alpha/beta Antibody Conjugated to PE
Catalog number:
B2016793
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 µg

More on eTradeWire News
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: Anti-TCR α/β
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Batard P, Szollosi J, Luescher I, Cerottini JC, MacDonald R, Romero P. Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations Cytometry. 2002 Jun 1;48(2):97-105.
2: Holsti MA, McArthur J, Allison JP, Raulet DH. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody J Immunol. 1994 Feb 15;152(4):1618-28.

https://moleculardepot.com/product/anti-tcr-alpha-beta-antibody-conjugated-to-pe/

Contact
Molecular Depot
info@molecular-depot.com
(858)900-3210


Source: Molecular Depot

Show All News | Report Violation

0 Comments

Latest on eTradeWire News